{"id":16082,"date":"2026-09-11T21:50:13","date_gmt":"2026-09-12T04:50:13","guid":{"rendered":"https:\/\/pandapeptides.com\/?page_id=16082"},"modified":"2026-09-11T21:50:13","modified_gmt":"2026-09-12T04:50:13","slug":"buffered-nad-500mg-coa-guide","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/buffered-nad-500mg-coa-guide\/","title":{"rendered":"How to Compare Buffered NAD+ 500mg Lab Reports"},"content":{"rendered":"

Compare buffered NAD+ 500mg reports by matching the material and lot, verifying the issuing laboratory, and reading identity, purity, and measured content separately.<\/strong> A strong comparison also distinguishes the supplier’s formulation description from the specific properties measured on the certificate.<\/p>\n

This Panda Peptides documentation guide works through an original ILS Laboratories report for NAD+ labeled 500mg. Read the complete two-page certificate<\/a> y verify it directly with ILS<\/a>. Report reviewed September 11, 2026.<\/p>\n

Start with a traceable report<\/h2>\n

The example is certificate COA-2026-FS81IM<\/strong>, lot PP2604-032<\/strong>, with an analysis date of September 3, 2026. It identifies NAD+, labeled content 500mg, tested for Panda Peptides. The certificate number and lot make the evidence specific and independently retrievable.<\/p>\n

Record the certificate alongside the supplier’s product specification and confirm the lot associated with an order. A 500mg report for one lot should remain clearly identified when other sizes or lots are also offered.<\/p>\n

Read all sample results, not just the headline<\/h2>\n

The certificate reports two samples:<\/p>\n

\n\n\n\n\n\n\n
ILS certificate COA-2026-FS81IM, page 1<\/caption>\n
Sample<\/th>\nHPLC purity<\/th>\nReported content<\/th>\nIdentity<\/th>\n<\/tr>\n<\/thead>\n
Dedicated V0<\/th>\n99.81%<\/td>\n531.44mg<\/td>\nConfirmed<\/td>\n<\/tr>\n
Conformity V1<\/th>\n98.57%<\/td>\n507.03mg<\/td>\nConfirmed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

Both sample rows are marked PASS in the certificate’s HPLC conformity section. Its reported means are 99.19% purity<\/strong> y 519.24mg content<\/strong>. The 99.81% headline is the Dedicated V0 result, not the two-sample mean. Keeping the sample labels visible makes a comparison easier to reproduce.<\/p>\n

ILS labels the mg field \u201cNet Peptide Content.\u201d That is the certificate’s field name; NAD+ itself is a nucleotide coenzyme, not a peptide. Preserve the laboratory’s units and method context when recording its result. A measured content result, a purity percentage, and the nominal 500mg label answer different questions.<\/p>\n

Separate NAD+ identity from buffer specifications<\/h2>\n

Panda’s product listing describes buffered NAD+ 500mg<\/a>. The example certificate reports NAD+ identity as \u201cConfirmed\u201d by HPLC-RTM<\/strong>. It does not list a measured pH or a quantitative buffer-composition result.<\/p>\n

For a laboratory comparing formulations, keep a separate specification field for the stated buffer and any required pH conditions. Look for a named measurement and result if those properties matter to the purchasing specification. NAD+ identity, buffer composition, and pH are distinct attributes; they should not be treated as interchangeable evidence.<\/p>\n

Compare additional panels on their own terms<\/h2>\n

The full ILS document also includes elemental-impurity, PCR sterility, endotoxin, and fentanyl-screen sections. Read each panel’s stated method, units, specification, and result. For example, preserve \u201cPCR\u201d when recording the microbial test; do not relabel it as a different compendial test.<\/p>\n

Use your laboratory’s documented acceptance criteria to decide which panels matter. A broad panel is useful because it supplies separate measurements, not because one PASS label makes all analytical methods equivalent. These results relate to the samples tested.<\/p>\n

A reusable comparison checklist<\/h2>\n